BIMERVAX

· Hipra Scientific, S.L.U

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for BIMERVAX, covering 2023-03-30 to 2026-08-04. Get the full timeline:

Most recent: EMA Authorised: Bimervax (COVID-19 Vaccine (recombinant, adjuvanted)) — Hipra Human Health S.L.